1cP-LSD Micro Pellets
1cP-LSD Micro Pellets - 10mcg Price range: € 10,00 through € 100,00
Back to products
Noopept Pellets omberacetam peptide-derived research material from Raw Lab Chems
Noopept Pellets - 10mg Price range: € 17,50 through € 500,00

Phenibut HCl Powder

Price range: € 60,00 through € 100,00

Phenibut HCl Powder is described as a synthetic phenyl-substituted gamma-aminobutyric acid analog supplied in hydrochloride salt form for controlled laboratory research.

Also known as beta-phenyl-GABA hydrochloride, the named compound contains a phenyl substituent on the beta carbon of the GABA-related molecular framework.

The supplied source identifies a crystalline powder presentation intended for analytical characterization, chemical identity investigation, and laboratory method development.

The reported molecular formula for the hydrochloride salt is C₁₀H₁₃NO₂·HCl, corresponding to an approximate molecular weight of 215.68 g/mol.

The source claims high purity, chromatographic testing, independent laboratory verification, and batch traceability. However, no actual Certificate of Analysis or supporting testing records were provided.

The reported solubility, melting point, particle size, and stability specifications also remain unverified for the actual batch.

Phenibut hydrochloride and phenibut free amino acid are chemically related but distinct material forms.

The powder is not established as a certified reference material, pharmaceutical-grade substance, or validated quantitative calibration standard.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-P-12950 Category:
Description

Phenibut HCl Powder – Phenyl-GABA Research Material

Product Overview

Phenibut HCl Powder is described as a synthetic research material containing phenibut hydrochloride, a phenyl-substituted analog of gamma-aminobutyric acid.

The named compound is commonly described as beta-phenyl-GABA hydrochloride.

Its structure contains a phenyl group attached to the beta carbon of a GABA-related molecular framework.

The hydrochloride designation identifies a salt form that is chemically distinct from the corresponding free amino acid.

The supplied source presents the material as a crystalline powder intended for controlled analytical and non-clinical laboratory research.

Its stated scientific context includes chemical identification, chromatographic characterization, structural investigation, physicochemical analysis, and analytical method development.

The source describes the material as high purity and pharmaceutical grade.

However, no actual batch-specific Certificate of Analysis, manufacturing documentation, or independent laboratory report accompanied those statements.

Accordingly, neither the claimed purity nor the pharmaceutical-grade designation can be treated as independently established.

The source also refers to extensive quality testing, batch traceability, and specialized shipping arrangements.

These remain supplier-provided claims rather than verified characteristics of the actual product.

The material is not established as a certified reference material, validated quantitative calibrator, or approved pharmaceutical preparation.

Chemical Identity & Classification

The supplied source identifies Phenibut HCl as the hydrochloride salt of a phenyl-substituted GABA analog.

The corresponding free amino acid is commonly named 4-amino-3-phenylbutanoic acid.

The supplied chemical information includes:

  • Common designation: Phenibut HCl
  • Alternative designation: Beta-phenyl-GABA hydrochloride
  • Descriptive chemical name: 4-Amino-3-phenylbutanoic acid hydrochloride
  • Reported hydrochloride CAS Registry Number: 3060-41-1
  • Related free amino acid CAS Registry Number: 1078-21-3
  • Reported salt formula: C₁₀H₁₃NO₂·HCl
  • Approximate hydrochloride molecular weight: 215.68 g/mol
  • Chemical classification: Phenyl-substituted GABA analog
  • Reported presentation: Crystalline powder
  • Intended designation: Research Use Only

The reported salt formula corresponds to a molecular weight of approximately 215.68 g/mol.

The corresponding free amino acid has a different molecular weight because it does not include the hydrochloride component.

These two chemical forms should not be treated as analytically identical.

The phenibut molecular framework contains a stereogenic carbon, but the supplied information does not establish whether the actual material is racemic or enriched in a particular stereoisomer.

No batch-specific stereochemical analysis was supplied.

The reported CAS identifiers and salt composition should be confirmed against authoritative chemical-reference information and actual batch documentation.

Researchers may consult PubChem for public chemical-reference information, ensuring that the selected entry corresponds to the hydrochloride salt rather than the free amino acid.

Chemical & Physical Characteristics

The supplied source describes Phenibut HCl as a fine white to off-white crystalline powder.

It also characterizes the material as free-flowing, non-hygroscopic under proper storage, and micronized.

No actual product-specific physical inspection report, particle-size distribution, or moisture-sorption study accompanied those statements.

The source reports a particle-size specification of D90 below 10 micrometers.

However, no laser-diffraction report, microscopy record, or other particle-size measurement was provided.

The reported particle-size claim therefore remains unverified.

The source also describes high aqueous solubility and gives a value above 100 mg/mL, alongside qualitative solubility statements for methanol, DMSO, and ethanol.

No product-specific solubility report, temperature specification, or validated solvent-comparison study accompanied those values.

The reported melting-point range is 194–197°C.

No thermal-analysis report was supplied to verify that range for the actual batch.

The hydrochloride salt designation is relevant to physicochemical characterization, but it does not independently establish the reported solubility or stability characteristics.

The source recommends sealed storage in a cool, dry environment protected from light and moisture.

No validated stability study was provided to confirm the reported storage conditions or shelf life.

Purity & Analytical Verification

The supplied source claims a purity of at least 99.5% by high-performance liquid chromatography.

It also reports individual impurity limits below 0.1%.

However, no actual batch-specific chromatogram, quantitative assay report, or Certificate of Analysis accompanied these statements.

The reported purity and impurity limits therefore remain unverified supplier claims.

The source describes an extensive analytical testing program that includes HPLC-UV/DAD, LC-MS, NMR spectroscopy, Karl Fischer moisture analysis, ICP-MS elemental screening, microbial testing, and endotoxin assessment.

No reports demonstrating completion of these tests for the actual product batch were supplied.

The source also claims third-party testing by ISO/IEC 17025-accredited laboratories.

No laboratory identity, accreditation scope, certificate number, or independent testing record was provided.

Accordingly, the claimed accreditation and third-party testing cannot be presented as verified product attributes.

The source further refers to compliance with USP and European Pharmacopoeia standards.

No applicable monograph, specification, validation report, or compliance certificate was supplied.

Pharmacopeial compliance should not be inferred from a list of analytical techniques.

The material is not established as a certified reference material or validated quantitative calibration standard.

Any definitive purity, impurity, accreditation, or pharmacopeial claims require actual supporting documentation.

Quality Control & Batch Integrity

The supplied source describes batch tracking, identity verification, impurity assessment, and detailed quality-control documentation.

It also claims full traceability from raw material sourcing through final packaging.

However, no actual manufacturing history, batch record, supplier qualification file, or independent audit report accompanied the information.

The source refers to serialized QR codes linked to digital Certificates of Analysis.

No sample label, functioning record link, or digital certificate was supplied.

These claims therefore remain unverified.

For reproducible laboratory documentation, relevant records may include verified chemical identifiers, confirmed hydrochloride salt composition, stereochemical information where available, batch number, analytical findings, receipt date, and available storage history.

Where particle-size and purity specifications are asserted, the corresponding batch-specific measurements are needed to establish those characteristics.

The source does not independently establish that every production batch meets a particular quality specification.  Phenibut HCl Powder

The Research Use Only designation describes intended positioning but does not demonstrate pharmaceutical-grade manufacturing, accreditation, or analytical traceability.

Claims of consistent quality should be supported by actual records.

Safety, Handling & Laboratory Precautions

Phenibut hydrochloride is a synthetic GABA-related compound associated with pharmacological activity and potentially significant exposure risks.

The supplied source does not provide a complete product-specific toxicological assessment.

Laboratory personnel should consult an applicable Safety Data Sheet and institutional chemical-safety procedures before receiving or examining the material.

Relevant precautions include controlled access, suitable personal protective equipment, prevention of dust inhalation, contamination control, and appropriate chemical-waste management.

Laboratory handling should be assessed according to the actual material properties and institutional risk evaluation.  Phenibut HCl Powder

The supplied source recommends a certified fume hood, but no product-specific exposure assessment was provided to establish that a particular engineering control is universally required.

The powder presentation does not establish safety for human or veterinary exposure.

The material should remain secured against unauthorized access and separated from food, beverages, and non-research environments.

Accidental exposure or contamination incidents should be managed according to institutional emergency procedures.

Packaging, Labeling & Storage

The supplied source describes tamper-evident containers, moisture-barrier packaging, temperature-controlled shipping, and international delivery arrangements.

No actual packaging-validation report, container specification, temperature-monitoring record, or shipping documentation accompanied these statements.

The source recommends storage at approximately 2–8°C in a sealed container protected from light and moisture.

However, no validated product-specific stability study was supplied to establish that temperature range as a verified requirement.

The source also claims a 24-month shelf life from manufacture under the recommended conditions.

No supporting accelerated-stability study, long-term stability report, or batch-specific expiration documentation was provided.  Phenibut HCl Powder

Accordingly, the stated shelf life remains unverified.

Laboratory inventory records should preserve the product designation, confirmed chemical form where available, batch identifier, receipt details, and relevant storage observations.

Storage requirements should be determined using verified stability evidence, available safety documentation, and institutional procedures.

Intended Research Use & Market Positioning

The supplied scientific context places phenibut hydrochloride within analytical research involving GABA-related chemical structures, hydrochloride salt characterization, and laboratory method development.

The compound’s phenyl-substituted molecular framework provides a structural distinction from gamma-aminobutyric acid itself.

The hydrochloride salt form also differs chemically from the corresponding free amino acid.

These characteristics are relevant to chemical identity assessment, chromatographic comparison, and physicochemical characterization.

The source describes research interest in structural analysis and receptor-associated molecular investigations.

However, no independently verified biological activity dataset or product-specific analytical validation report was supplied.  Phenibut HCl Powder

The supplied Raw Lab Chems catalog includes Phenibut HCl Powder, corresponding to the listing discussed here.

For comparative product-format context, Raw Lab Chems also lists Phenibut HCl Vega Caps and Phenibut FAA Vega Caps.

The hydrochloride capsule listing refers to the same named salt form in a different presentation.

The FAA listing refers to the corresponding free amino acid form.

These forms should not be treated as having identical molecular weights or quantitative analytical characteristics.

The supplied information does not establish equivalent ingredient purity, excipient composition, finished-unit content, or analytical specifications across the listings.

These references provide catalog context rather than evidence of product equivalence or certified reference-material status.

Ordering, Availability & Fulfillment

The supplied source describes multiple quantity options, specialized packaging, insured international shipping, tracking, and expedited delivery.

No current inventory record, confirmed pack-size listing, carrier agreement, shipment authorization, or verified delivery information was supplied.

The source also claims typical worldwide delivery within several business days and temperature-controlled transportation.

No supporting logistics documentation accompanied those statements.

Consequently, no stock, delivery-time, temperature-control, customs-clearance, or transportation-compliance guarantee is asserted.

The regulatory treatment of phenibut hydrochloride varies by jurisdiction and may involve pharmaceutical, chemical, customs, or other restrictions.

Institutional acquisition, possession, transportation, importation, and exportation should be assessed under applicable laws.

Research-only labeling does not independently establish a regulatory exemption.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Phenibut hydrochloride is a synthetic phenyl-substituted GABA analog whose regulatory treatment may differ between jurisdictions.

The supplied source describes the product as exempt from dietary-ingredient requirements and makes broad claims concerning transport classification and legal compliance.

No regulatory determination, exemption certificate, transport classification report, or jurisdiction-specific legal assessment accompanied those claims.

Accordingly, no universal regulatory exemption or non-hazardous transportation classification is asserted.

Institutions remain responsible for determining applicable acquisition, possession, transport, import, export, and laboratory-use requirements.

No pharmaceutical approval, consumer-use authorization, or regulatory exemption is implied by this description.

Additional information
Quantity (25 g)

2

,

4

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Phenibut HCl Powder”
Shipping & Delivery